Hosenpud J D, Stibolt T A, Atwal K, Shelley D
Department of Medicine, Oregon Health Sciences University, Portland 97201.
Am J Med. 1990 May;88(5):493-6. doi: 10.1016/0002-9343(90)90428-g.
A variety of abnormalities in pulmonary function have been attributed to, or are believed to be, exacerbated by congestive heart failure. Separating out specific contributions from cardiac versus pulmonary disease is difficult. In order to investigate the impact of cardiac disease on pulmonary function, we performed spirometry on patients immediately before and after cardiac transplantation.
Seventeen patients (13 men, 4 women) with a mean age of 44 years (range: 20 to 62 years) were studied before and 15 +/- 10 (mean +/- SD) months after cardiac transplantation. Eleven patients had a significant smoking history.
In comparing pre- and post-transplant spirometric results, forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) increased substantially after transplant (3.34 +/- 0.96 L versus 3.89 +/- 1.00 L, p = 0.0054, and 2.63 +/- 0.80 L versus 2.95 +/- 0.83 L, p = 0.042, respectively). FEV1/FVC was not significantly different between study states in the entire group (0.78 +/- 0.10 versus 0.76 +/- 0.10, p = NS), nor was it different in those patients with and without a smoking history (0.76 +/- 0.11 versus 0.72 +/- 0.10, p = NS, and 0.87 +/- 0.06 versus 0.84 +/- 0.02, p = NS, respectively). Furthermore, normal lung volumes were obtained after transplant in those patients without a smoking history in contrast to those with a smoking history. Finally, the increase in FVC after cardiac transplantation directly correlated with the decrease in cardiac volume with cardiac replacement (r = 0.83, p less than 0.0001).
We conclude that in patients selected as cardiac transplant candidates (those without severe obstructive lung disease), restrictive but not obstructive pulmonary physiology can be attributed in part to congestive heart failure, and a major part of the reduction in lung volumes is secondary to the space occupied by a large heart. Other factors, such as accompanying pleural effusions and interstitial edema, likely contribute to the reduction in lung volumes. Abnormal pulmonary function secondary to chronic congestive heart failure in this selected population is completely reversible with normalization of cardiovascular physiology and anatomy.
多种肺功能异常被认为与充血性心力衰竭有关,或被认为会因充血性心力衰竭而加重。区分心脏疾病和肺部疾病的具体影响很困难。为了研究心脏疾病对肺功能的影响,我们在心脏移植前后即刻对患者进行了肺活量测定。
对17例患者(13例男性,4例女性)进行了研究,平均年龄44岁(范围:20至62岁),在心脏移植前以及移植后15±10(平均±标准差)个月进行测定。11例患者有显著吸烟史。
比较移植前后的肺活量测定结果,移植后用力肺活量(FVC)和第1秒用力呼气量(FEV1)显著增加(分别为3.34±0.96L对3.89±1.00L,p = 0.0054;2.63±0.80L对2.95±0.83L,p = 0.042)。整个组中研究状态之间的FEV1/FVC无显著差异(0.78±0.10对0.76±0.10,p =无统计学意义),有吸烟史和无吸烟史的患者之间也无差异(分别为0.76±0.11对0.72±0.10,p =无统计学意义;0.87±0.06对0.84±0.02,p =无统计学意义)。此外,无吸烟史的患者移植后肺容积正常,而有吸烟史的患者则不然。最后,心脏移植后FVC的增加与心脏置换后心脏容积的减少直接相关(r = 0.83,p<0.0001)。
我们得出结论,在被选为心脏移植候选者的患者(那些没有严重阻塞性肺病的患者)中,限制性而非阻塞性肺生理部分可归因于充血性心力衰竭,肺容积减少的主要部分是继发于大心脏所占据的空间。其他因素,如伴随的胸腔积液和间质性水肿,可能也导致了肺容积的减少。在这个特定人群中,慢性充血性心力衰竭继发的异常肺功能随着心血管生理和解剖结构的正常化是完全可逆的。